These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 28840541)
1. Drugs in Clinical Development for Fungal Infections. Gonzalez-Lara MF; Sifuentes-Osornio J; Ostrosky-Zeichner L Drugs; 2017 Sep; 77(14):1505-1518. PubMed ID: 28840541 [TBL] [Abstract][Full Text] [Related]
2. Recent approaches to antifungal therapy for invasive mycoses. Mathew BP; Nath M ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of the Orotomides against Hope WW; McEntee L; Livermore J; Whalley S; Johnson A; Farrington N; Kolamunnage-Dona R; Schwartz J; Kennedy A; Law D; Birch M; Rex JH mBio; 2017 Aug; 8(4):. PubMed ID: 28830945 [TBL] [Abstract][Full Text] [Related]
4. Antifungals in Clinical Use and the Pipeline. Johnson MD Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281 [TBL] [Abstract][Full Text] [Related]
5. Systemic Antifungal Agents: Current Status and Projected Future Developments. Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500 [TBL] [Abstract][Full Text] [Related]
6. Management of invasive fungal infections: a role for polyenes. Chandrasekar P J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787 [TBL] [Abstract][Full Text] [Related]
8. The value of amphotericin B in the treatment of invasive fungal infections. Klepser M J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541 [TBL] [Abstract][Full Text] [Related]
9. Antifungal drugs: What brings the future? Van Daele R; Spriet I; Wauters J; Maertens J; Mercier T; Van Hecke S; Brüggemann R Med Mycol; 2019 Jun; 57(Supplement_3):S328-S343. PubMed ID: 31292663 [TBL] [Abstract][Full Text] [Related]
10. New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species. Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Dos Santos ALS Curr Top Med Chem; 2019; 19(28):2527-2553. PubMed ID: 31654512 [TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Delattin N; Cammue BP; Thevissen K Future Med Chem; 2014 Jan; 6(1):77-90. PubMed ID: 24358949 [TBL] [Abstract][Full Text] [Related]
12. Currently used antimycotics: spectrum, mode of action and resistance occurrence. Francois IE; Aerts AM; Cammue BP; Thevissen K Curr Drug Targets; 2005 Dec; 6(8):895-907. PubMed ID: 16375673 [TBL] [Abstract][Full Text] [Related]
13. Antifungal drugs on the horizon. Hay RJ J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S82-6. PubMed ID: 8077515 [TBL] [Abstract][Full Text] [Related]
14. Antifungal drug resistance to azoles and polyenes. Masiá Canuto M; Gutiérrez Rodero F Lancet Infect Dis; 2002 Sep; 2(9):550-63. PubMed ID: 12206971 [TBL] [Abstract][Full Text] [Related]
15. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
16. The antifungal arsenal: alternative drugs and future targets. Wiederhold NP Int J Antimicrob Agents; 2018 Mar; 51(3):333-339. PubMed ID: 28890395 [TBL] [Abstract][Full Text] [Related]
17. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]. Schäfer-Korting M Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850 [TBL] [Abstract][Full Text] [Related]
18. How urgent is the need for new antifungals? Stewart AG; Paterson DL Expert Opin Pharmacother; 2021 Oct; 22(14):1857-1870. PubMed ID: 34231434 [No Abstract] [Full Text] [Related]